Aparicio, L., Crowley, L., Christin, J. R., Laplaca, C. J., Hibshoosh, H., Rabadan, R., & Shen, M. M. (2025). Meta-analyses of mouse and human prostate single-cell transcriptomes reveal widespread epithelial plasticity in tissue regression, regeneration, and cancer. Genome Medicine, 17(1). https://doi.org/10.1186/s13073-025-01432-w

De Felice, D., Alaimo, A., Bressan, D., Genovesi, S., Marmocchi, E., Annesi, N., Beccaceci, G., Dalfovo, D., Cutrupi, F., Medaglia, S., Foletto, V., Lorenzoni, M., Gandolfi, F., Kannan, S., Verma, C. S., Vasciaveo, A., Shen, M. M., Romanel, A., Chiacchiera, F., … Lunardi, A. (2024). Rarγ-Foxa1 signaling promotes luminal identity in prostate progenitors and is disrupted in prostate cancer. EMBO Reports. https://doi.org/10.1038/s44319-024-00335-y

Sadasivan, S. M., Loveless, I. M., Chen, Y., Gupta, N. S., Sanii, R., Bobbitt, K. R., Chitale, D. A., Williamson, S. R., Rundle, A. G., & Rybicki, B. A. (2024). Patterns of B‐cell lymphocyte expression changes in pre‐ and post‐malignant prostate tissue are associated with prostate cancer progression. Cancer Medicine, 13(6). Portico. https://doi.org/10.1002/cam4.7118

Su, J., Reynier, J.-B., Fu, X., Zhong, G., Jiang, J., Escalante, R. S., Wang, Y., Aparicio, L., Izar, B., Knowles, D. A., & Rabadan, R. (2023). Smoother: a unified and modular framework for incorporating structural dependency in spatial omics data. Genome Biology, 24(1). https://doi.org/10.1186/s13059-023-03138-x

Wei, X., Zhang, L., Zhang, Y., Cooper, C., Brewer, C., Tsai, C.-F., Wang, Y.-T., Glaz, M., Wessells, H. B., Que, J., Titus, M. A., Cirulli, V., Glaser, A., Liu, T., Reder, N. P., Creighton, C. J., & Xin, L. (2022). Ablating Lgr5-expressing prostatic stromal cells activates the ERK-mediated mechanosensory signaling and disrupts prostate tissue homeostasis. Cell Reports, 40(10), 111313. https://doi.org/10.1016/j.celrep.2022.111313

Movassaghi, M., Ahmed, F., Patel, H., Luk, L., Hyams, E., Wenske, S., & Shaish, H. (2022). Association of Patient and Imaging-Related Factors With False Negative MRI-Targeted Prostate Biopsies of Suspicious PI-RADS 4 and 5 Lesions. Urology, 167, 165–170. https://doi.org/10.1016/j.urology.2022.04.026

Patel, H., Ahmed, F., Luk, L., Navot, B., & Shaish, H. (2022). Impact of enema prep on the false-negative rate of a PI-RADS 1 MRI of the prostate for clinically significant prostate cancer. Abdominal Radiology, 47(7), 2494–2499. https://doi.org/10.1007/s00261-022-03547-9

Cambuli, F., Foletto, V., Alaimo, A., De Felice, D., Gandolfi, F., Palumbieri, M. D., Zaffagni, M., Genovesi, S., Lorenzoni, M., Celotti, M., Bertossio, E., Mazzero, G., Bertossi, A., Bisio, A., Berardinelli, F., Antoccia, A., Gaspari, M., Barbareschi, M., Fiorentino, M., … Lunardi, A. (2022). Intra‐epithelial non‐canonical Activin A signaling safeguards prostate progenitor quiescence. EMBO Reports, 23(5). Portico. https://doi.org/10.15252/embr.202154049

Abate-Shen, C., & Nunes de Almeida, F. (2022). Establishment of the LNCaP Cell Line – The Dawn of an Era for Prostate Cancer Research. Cancer Research, 82(9), 1689–1691. https://doi.org/10.1158/0008-5472.can-22-1065

Rybicki, B. A., Sadasivan, S. M., Chen, Y., Loveless, I., Gupta, N. S., Chitale, D. A., Williamson, S. R., Rundle, A. G., & Tang, D. L. (2022). Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention, 31(5), 991–998. https://doi.org/10.1158/1055-9965.epi-21-1221